Ovarian steroids and control of proliferation in the normal human breast

Breast

Volumn 10, Issue 4, 2001, Pages 273-278

  Anderson, E ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MITOGENIC AGENT; PROGESTERONE; SEX HORMONE; STEROID;

BREAST CANCER; BREAST EPITHELIUM; CANCER RISK; CELL POPULATION; CELL PROLIFERATION; EPITHELIUM CELL; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MEDICAL LITERATURE; MENOPAUSE; OVARY; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 0034925266     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0258     Document Type: Article

References (49)

1. Clinical evidence on the role of oestrogens in the development of the breasts
2. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
3. Mammary gland development and tumorigenesis in estrogen receptor knockout mice
4. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
5. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast
6. More about: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
7. More about: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
8. Development of the human mammary gland
9. Frequency and distribution of estrogen receptor positive cells in normal, nonlactating human breast tissue
10. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions
11. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: Relation to in vivo phenotypes and influence of medium
12. Patterns of reaction of monoclonal antibodies HMFG-1 and 2 with benign breast tissues and breast carcinomas
13. Cyclic variation of DNA synthesis in human breast epithelium
14. Cell proliferation in normal human breast ducts, fibroadenomas and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age and oral contraceptive hormones
15. Cell turnover in the "resting" human breast: Influence of parity, oral contraceptive pill, age and laterality
16. Proliferative and secretory activity and human breast tissue during natural and artificial menstrual cycles
17. The effect of age and menstrual cycle upon proliferative activity of the normal human breast
18. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use and reproductive factors
19. Proliferation of breast epithelial cells in healthy women during the menstrual cycle
20. bcl-2 expression in normal human breast tissue during the menstrual cycle
21. Epidermal growth factor receptor and c-erbB-2 expression in normal breast during the menstrual cycle
22. A correlative morphologic study of human breast and endometrium in the menstrual cycle
23. An immunomagnetic separation using supraparamagnetic (MACS) beads for large scale purification of human mammary luminal and myoepithelial cells
24. The MCF10 family of spontaneously immortalised human breast epithelial cell lines: Models of neoplastic progression
25. Growth requirements and neoplastic transformation of two types of normal human breast epithelial cells derived from reduction mammoplasty
26. Human breast epithelium in vitro: The re-expression of structural and functional cellular differentiation in long term culture
27. Effects on growth factors on proliferation of basal and luminal epithelial cells in human breast epithelial explants in serum-free culture
28. Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: Immunocytochemical studies
29. Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines
30. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor
31. Characterisation of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA
32. Characterisation of the estrogen receptor transfected MCF10A breast cell line 139B6
33. Estrogen and progesterone receptors can be maintained in normal human breast epithelial cells in primary culture and after transplantation into nude mice
34. The effect of estrogen, progesterone, thyroxine and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice
35. Human breast epithelium transplanted into nude mice. Proliferation and milk protein production in response to pregnancy
36. Transplantation of human breast epithelia to mammary-gland-free fat pads of athymic nude mice: Influence of mammotrophic hormones on growth of breast epithelia
37. Human breast epithelial xenografts: An immunocytochemical and ultrastructural study of differentiation and lactation
38. Reconstituted human normal breast in nude mice using collagen gel or Matrigel
39. Proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone
40. Estrogen sensitivity of normal human breast in vivo and implanted into athymic nude mice: Analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression
41. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle
42. Estrogen and progestin regulation of cell cycle progression
43. A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: Enhanced proliferative response to estrogen in late postmenopausal mice
44. Re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
45. Dissociation between steroid receptor expression and cell proliferation in the human breast
46. Role of hormones in mammary cancer initiation and progression
47. Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland
48. Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions
49. Evidence that transforming growth factor β is a hormonally-regulated negative growth factor in human breast cancer cells